FDA Approved: SEVELAMER CARBONATE — Original Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved NorthStar RxLLC's generic sevelamer carbonate (ANDA 207291) for the treatment of hyperphosphatemia in adults with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

ORIG AP for SEVELAMER CARBONATE (SEVELAMER CARBONATE)